Ticker Scorecard - UTHR Basics Company: United Therapeutics Corporation IPO Date: June 17, 1999 Sector: Healthcare Industry: Biotech Market Cap: $16.12B Activated in VL: True Average Daily Range Avg Daily Range: $1.54 | 1.39% Avg Daily Range (30 D): $5.00 | 1.38% Avg Daily Range (90 D): $4.94 | 1.34% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .23M Trade Size Avg Trade Size (Sh.): 121 Avg Trade Size (Sh.) (30 D): 28 Avg Trade Size (Sh.) (90 D): 27 Institutional Trades Total Inst.Trades: 14,036 Avg Inst. Trade: $4.43M Avg Inst. Trade (30 D): $16.38M Avg Inst. Trade (90 D): $17.04M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $8.35M Avg Closing Trade (30 D): $21.47M Avg Closing Trade (90 D): $22.11M Avg Closing Volume: 56.85K     News Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Aug 6, 2024 @ 10:20 AM Should You Invest in the First Trust NYSE Arca Bio... Source: Zacks Investment Research Jul 31, 2024 @ 1:30 PM United Therapeutics (UTHR) Reports Q2 Earnings: Wh... Source: Zacks.Com Jul 12, 2024 @ 11:41 AM These are the top stocks for Q2 earnings season ac... Source: Thomas Monteiro Jul 11, 2024 @ 8:11 AM 'We downgrade Darden stock on weaker near-term fun... Source: Emilio Ghigini Financials   TTM Q3 2024 Q2 2024 Basic EPS $24.33 $6.93 $6.26 Diluted EPS $22.76 $6.39 $5.85 Revenue $ 2.76B $ 748.9M $ 714.9M Gross Profit $ 2.45B $ 665.8M $ 637.1M Net Income / Loss $ 1.11B $ 309.1M $ 278.1M Operating Income / Loss $ 1.28B $ 343.1M $ 319.9M Cost of Revenue $ 304.8M $ 83.1M $ 77.8M Net Cash Flow $ 446.2M $ 198.2M $ 104.2M PE Ratio 15.87     Splits Sep 23, 2009:   1:2